In addition, p53 can reduce COX-2 expression [20], another inflammatory mediator involved in lung cancer development and progression [21], and loss of p53 activity may contribute to the persistent elevation of COX-2 in epithelial stroma and lung cancer cells. The gene discussed is TP53; the disease is lung carcinoma.